Eriko Ichikawa

844 citations
28 papers · 641 indexed · h-index 16
Topics
Toxin Mechanisms and Immunotoxins (6 papers)Glycosylation and Glycoproteins Research (4 papers)Cancer and Skin Lesions (3 papers)
Partner nations
JapanUnited KingdomIndia

In The Last Decade

Eriko Ichikawa

28 papers receiving 621 citations

Peers

Eriko Ichikawa
Comparison fields: 5 of 105
  • Molecular Biology 192
  • Dermatology 164
  • Immunology 103
  • Epidemiology 100
  • Cognitive Neuroscience 87
Replace Kathrin Kalies with:
Kathrin Kalies Germany
Dimitra Beroukas Australia
William B. Rinehart United States
Antonio Di Zazzo Italy
Shuang Wu United States
R Manabe Japan
A. Кlеіn Germany
Monika Ołdak Poland
T. Yagi Japan
Ki‐Heon Jeong South Korea
Eriko Ichikawa relative to Kathrin Kalies Germany Kathrin Kalies's profile →
Citations per field
00.5×4.0×
Kathrin Kalies · 1×
Citations per year

Countries citing papers authored by Eriko Ichikawa

Since Specialization
Citations

This map shows the geographic impact of Eriko Ichikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eriko Ichikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eriko Ichikawa more than expected).

Fields of papers citing papers by Eriko Ichikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eriko Ichikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eriko Ichikawa. The network helps show where Eriko Ichikawa may publish in the future.

Co-authorship network of co-authors of Eriko Ichikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Eriko Ichikawa. A scholar is included among the top collaborators of Eriko Ichikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eriko Ichikawa. Eriko Ichikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 51
3 33
4 9
5 22
6 12
7 6
8 26
9 95
10 30
11 14
12 23
13 1
14 1
15 12
16 8
17 14
18 20
19 15
20 80

About Eriko Ichikawa

Eriko Ichikawa is a scholar working on Dermatology, Immunology and Allergy and Immunology, having authored 28 papers that have together received 641 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Cancer and Skin Lesions (3 papers). The work is most often cited by research in Dermatology (164 citations), Immunology and Allergy (83 citations) and Immunology (103 citations). Eriko Ichikawa has collaborated with scholars based in Japan, United Kingdom and India. Frequent co-authors include Kazuhisa Taketa, Hiroko Taga, Fujio Otsuka, Hidematsu Hirai, Tadao Arinami, Emiko Noguchi, Shinichi Watanabe, Hisashi Takahashi, Masashi Kamioka and M. Shibasaki. Their work appears in journals such as Annals of the New York Academy of Sciences, Cancer Letters and Journal of Immunological Methods.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026